Rekonnect is a B2B solution for medical technology companies to comply with the post-market surveillance requirements of MDR.
Rekonnect has raised $441K in total funding. The most recent round was Pre-Seed. The last funding was announced in February 2023.
Rekonnect's investors include Loop Capital, Skåne Ventures, Curus, AngCell Ventures, Emil Sjödin.
Rekonnect is headquartered in Malmö, Sweden.
Rekonnect is a B2B solution for medical technology companies to comply with the post-market surveillance requirements of MDR.
Rekonnect is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Rekonnect — Funding & Investors." VCBacked, February 15, 2023, https://www.vcbacked.co/company/rekonnect. Accessed August 14, 2026.
VCBacked. (2023). Rekonnect — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/rekonnect
{{cite web |title=Rekonnect — Funding & Investors |url=https://www.vcbacked.co/company/rekonnect |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated